Skip to the page

Data / Form D filings / TuHURA Biosciences, Inc./NV

TuHURA Biosciences, Inc./NV: Form D filings

TuHURA Biosciences, Inc./NV, a biotechnology company in Tampa, FL, filed 9 Form D notices with the SEC between 2013 and 2025. The latest, on November 10, 2025, reports $1.5 million sold of a $3 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
10500 UNIVERSITY CENTER DR., SUITE 110, Tampa, FL, 33612
Phone
(813) 875-6600
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Nevada
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1498382

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 10, 2025New notice$3,000,000$1,500,000$1,500,0001Oct 27, 2025sec.gov
Jun 13, 2025New notice$12,612,120$2,228,043$10,384,07736Jun 2, 2025sec.gov
Aug 28, 2020New notice$30,000,000$21,772,000$8,228,000161Aug 19, 2020sec.gov
Aug 27, 2020New notice$30,000,000$21,772,000$8,228,000161Aug 19, 2020sec.gov
May 10, 2016New noticeIndefinite$5,600,00085Apr 29, 2016sec.gov
Mar 7, 2013Amendment$10,500,000$10,500,000102Jan 25, 2013sec.gov
Feb 14, 2013Amendment$10,000,000$7,928,550$2,071,45070Jan 25, 2013sec.gov
Feb 8, 2013Amendment$10,000,000$6,887,450$3,112,55048Jan 25, 2013sec.gov
Feb 8, 2013New notice$10,000,000$6,887,450$3,112,55048Jan 25, 2013sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Alan ListDirector
Craig TendlerDirector
George NgDirector
Robert HoffmanDirector
James BiancoExecutive Officer, Director
James ManusoDirector
Dan DearbornExecutive Officer

Other biotechnology companies in Florida that filed recently

Every Form D from the week of Nov 10, 2025 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what TuHURA Biosciences, Inc./NV reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.